Special Issue "MicroRNAs Applications in Cancer, Therapeutics and Related Toxicities"
Deadline for manuscript submissions: closed (25 October 2021).
Knowledge about microRNAs (miRNAs) has dramatically expanded during the last decade, showing their important role in many diseases and cancer, as well as in the response to therapeutic approaches. Therefore, specific signatures of aberrantly expressed miRNAs harbor diagnostic, prognostic, and therapeutic implications. Changes in miRNA expression occur in response to environmental stimuli and play an important role in the regulation of cancer development and aggressiveness, immune response, and specific treatment efficacy. Currently, there is a critical need to discover biomarkers for risk prediction and early diagnosis of cancer, to monitor progression and to predict clinical outcome, and miRNAs are strong candidates for all these.
This Special Issue intends to present original research and reviews in the field of miRNA application in cancer as targeted biomarkers for prognosis, therapeutic efficacy, and therapeutic related toxicities. It also will include the topic of miRNA application in cancer immunotherapy.
Dr. Enrique Fuentes-Mattei
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Genes is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- noncoding RNAs
- cancer therapeutics
- radiation oncology